Exploring cyanobacterial compounds for new cancer treatments
Cyanobacterial pseudo-natural products for anticancer drug discovery
This study is exploring new cancer-fighting drugs made from natural substances found in cyanobacteria, aiming to create better treatments that specifically target cancer cells to help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Puerto Rico Med Sciences NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project ID | NIH-10663360 on NIH RePORTER |
What this research studies
This research focuses on developing new anticancer drugs derived from cyanobacteria, which are known to produce compounds with strong cancer-fighting properties. The team will create a library of synthetic compounds inspired by these natural products, using advanced techniques in medicinal chemistry and machine learning to analyze their effectiveness. By comparing these new compounds to existing cancer treatments, the goal is to discover innovative therapies that specifically target cancer cells. Patients may benefit from more effective and targeted cancer treatments as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with various types of cancer who may benefit from novel anticancer therapies.
Not a fit: Patients with non-malignant conditions or those who do not have cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, more effective cancer treatments that specifically target tumor cells.
How similar studies have performed: Previous research has shown promise in using natural products for drug discovery, indicating that this approach could yield significant advancements in cancer treatment.
Where this research is happening
San Juan, United States
- University of Puerto Rico Med Sciences — San Juan, United States (Active)
Researchers
- Principal investigator: Caro, Eduardo Javier — University of Puerto Rico Med Sciences
- Study coordinator: Caro, Eduardo Javier
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.